MGO One Seven LLC Increases Holdings in Synopsys, Inc. $SNPS

MGO One Seven LLC raised its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 268.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,523 shares of the semiconductor company’s stock after buying an additional 3,294 shares during the quarter. MGO One Seven LLC’s holdings in Synopsys were worth $2,232,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Norges Bank purchased a new stake in shares of Synopsys in the second quarter valued at about $647,964,000. Ameriprise Financial Inc. boosted its holdings in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares during the last quarter. Ninety One UK Ltd purchased a new stake in shares of Synopsys in the 3rd quarter valued at approximately $249,851,000. Aspex Management HK Ltd grew its stake in shares of Synopsys by 106.0% in the 2nd quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock valued at $331,137,000 after buying an additional 332,364 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of Synopsys by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after buying an additional 231,014 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SNPS shares. Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. BNP Paribas assumed coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Needham & Company LLC upped their target price on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Rosenblatt Securities raised shares of Synopsys from a “neutral” rating to a “buy” rating and lowered their target price for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Finally, Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Nine research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $553.57.

Check Out Our Latest Stock Report on Synopsys

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 4,157 shares of company stock valued at $1,945,036. Insiders own 0.62% of the company’s stock.

Synopsys Stock Performance

NASDAQ SNPS opened at $505.34 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The company has a market cap of $96.68 billion, a P/E ratio of 63.25, a P/E/G ratio of 4.26 and a beta of 1.12. The stock has a 50-day moving average of $450.65 and a two-hundred day moving average of $505.02. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter last year, the firm posted $3.40 earnings per share. The business’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.